News Articles 1 - 10 of 160

PSC Support Research Grants
News Type: BASL News

PSC Support is inviting funding applications for:

• Project Award £50,000 - worldwide (closing date 01 May 2024)
• Seed Funding Awards £15,000 to generate pilot or proof-of-concept data - worldwide (closing date 01 May 2024)
• Research Training Fellowship (£300,000) - UK-only (closing date 01 June 2024)

More information:

New technology could spot and treat liver cirrhosis complications sooner
News Type: BASL News

A new study is recruiting now. The research will look at the CirrohCare system for managing and treating decompensated cirrhosis. The system uses smart devices to let people check their condition at home. Doctors can see the data in real time with algorithms helping to spot potential problems early. A preliminary study found positive responses from patients and a reduction in hospital treatment.
Find out more

British Liver Trust

Putting a spotlight on liver health: an update from the UK Liver Alliance
News Type: BASL News

Join this webinar on Tuesday, 9th April at 5pm for an exclusive update from the UK Liver Alliance, a coalition of more than 30 organisations who are committed to improving liver health. 

From pioneering efforts in early detection within primary care to initiatives aimed at reducing variation in hospital care and driving policy change, this event promises insights that are both informative and inspiring.  Speakers include Professor Phil Newsome, Dr Rebecca Jones, Dr Andrew Yeoman and Dr Helen Jarvis.

Register here 

The SHiNE-UK Study (Surveillance and Care for HCC: A National Evaluation) is now live
News Type: BASL News

The SHiNE-UK study (Surveillance and Care for HCC: A National Evaluation) is now live.

Further information and all study docs are available on REDCap dashboard here;

Do you want to help to research an increasingly important clinical question in hepatology? Do you want to get involved in a large national collaborative project with PubMed-cited collaborative authorship?

SHiNE-UK (Surveillance and care for Hepatocellular carcInoma: a National Evaluation) is a multi-centre project aiming to understand HCC surveillance adherence and outcomes, routes to diagnosis and treatment utilisation across the UK.

SHiNE-UK is a trainee-led multicentre retrospective study that is led by the Trainee Collaborative for Research and Improvement for Hepatology (ToRcH-UK) and hosted by Manchester University NHS Foundation Trust. I

This project comprises of 3 threads:
• Survey of the current provision of HCC surveillance and care (site leads only)
• To assess HCC surveillance adherence and outcomes for patients active in surveillance (all sites – projected 20-60 cases per site)
• To assess routes to diagnosis and first line treatment utilisation for incident HCC (network HPB MDT sites only – projected 30-90 cases per site)

All clinicians, including specialist nurses and allied health professionals are encouraged to take part. Local project teams will gather retrospective data between February and July 2024. All data will be submitted anonymously on REDCap. Each site will have a site lead (registrar) with a supervising gastroenterology/hepatology consultant. The study can be registered via your local Audit Department and will not require R&D approval.

If you would like to take part, please access the SHiNE-UK study dashboard which provides the protocol and supporting materials

Key Dates
27-Nov-2023 - Site registration opens
19-Feb-2024 - REDCap data collection opens
30-Apr-2024 - Site registration closes
31-Jul-2024 - REDCap data collection closes

Download SHiNE-UK Promotional Poster v1.0 04-Feb-24.pdf

If you have any questions, please contact us via We look forward to working with you on this exciting project!

Best wishes
SHiNE-UK Project Management Group

X @SHiNEUK_study 

Clinical Research Fellow - Hepatology - NDM Experimental Medicine, John Radcliffe Hospital, Oxford.
News Type: BASL News

About the Role

We are seeking to appoint a highly motivated, clinically qualified candidate (with an interest in hepatology, hepatobiliary surgery or oncology) to join our established, multi-disciplinary team, to undertake a clinical fellowship in liver cancer early detection. The post is full time, for 3 years, and the successful applicant would be expected to register for a DPhil (PhD). Your fees for the DPhil will be paid.

You will play an active role in the execution of clinical studies within DeLIVER (, a CRUK funded program that seeks to detect hepatocellular liver cancer (HCC) early.

You will be responsible for supporting the DeLIVER team in acquiring liver tissue by i) performing fine needle aspirations/liver biopsy, and ii) by liaising with the interventional radiologists and hepatobiliary surgeons. This program would involve the evaluation of biomarkers (immune and/or genetic) in blood, HCC, and the back-ground liver, that will support early cancer detection and enhance our understanding of pathways in the liver that lead to HCC transformation.

Informal queries may be addressed to Prof Ellie Barnes, .

A link to the full application can be found here: Job Details (

Please note the tight deadlines – the application closes on 15th March, with interviews expected on the 25th or 26th March 2024

Foundation for Liver Research 2024 Legacy Grant Scheme Call now open
News Type: BASL News

The Foundation for Liver Research has created the Legacy Grants Scheme in memory of the late Professor Roger Williams CBE (1931-2020). This scheme is open to any applicant in the UK and has one annual funding Call in Spring each year.

This translational research funding scheme will award one grant of up to £50,000 to support experimental studies in the field of liver research.

The aim of this translational research scheme is to support experimental studies in the following key areas of liver disease:

(1) Improved understanding of the pathogenesis of liver disease

(2) The development of accurate diagnostic tests, identification of early risk biomarkers, and exploration of protective and therapeutic vaccination strategies for liver disease.

(3) Accelerated translation of research discoveries from bench-to-bedside

Further information is available in the Scheme Overview below and full details can be found on the Foundation for Liver Research website > Here .

Download Legacy Grants Scheme_Overview 2024.pdf 

Closing date 5pm Friday 12th April 2024

For further details or in case of queries, please contact  

Closure of HCV Research UK
News Type: BASL News

As many in the hepatology community are aware, HCV Research UK has been operating for more than a decade, providing clinical data and biological samples from a national cohort to support research studies into HCV infection. In total, more than 100 applications for accessing data and samples have been approved, enabling unique insight into the characteristics of infection, pathogenesis and the mechanisms underlying treatment response.

With the advent of direct acting antivirals and the progress towards elimination, there are now few applications requesting access to the resources. In addition, the clinical database has not been updated for several years. As a consequence, the HCV Research UK Management Group has decided to close provision of data and samples by the end of this year. Therefore, we would urge anyone who may wish to use the clinical data and biological samples to lodge applications by the end of May 2024. The process for applying to access HCV Research UK resources can be found at . We also suggest contacting either Will Irving ( or John McLauchlan ( in the first instance. This would allow sufficient time to process the applications, complete the necessary MTAs, prepare the clinical data and set aside any samples that would be needed for any research studies.

The Management Group wishes to express its gratitude to the clinical teams and HCV Research UK staff whose commitment and efforts enabled the creation of a national cohort. Finally, we will be forever grateful to the individuals living with the virus who generously provided their clinical data and samples to the benefit of studies that have deepened our knowledge of HCV infection.

HCV Research UK Management Group

Professor Will Irving (University of Nottingham)
Professor John McLauchlan (University of Glasgow)
Professor John Dillon (University of Dundee)
Professor Sharon Hutchinson (Glasgow Caledonian University

British Liver Trust Love Your Liver Awareness Month - January 2024
News Type: BASL News

January is Love Your Liver Awareness month a campaign ran by the British Liver Trust. The key aim of the month is to put a spotlight on liver disease risk factors and the steps we can take to keep our livers healthy.

The liver is a vital organ with an amazing ability to regenerate. Performing over 500 jobs, including producing energy and fighting infection, it works hard and can tolerate a lot of abuse. But like an elastic band – it can only stretch so far before it breaks. Taking steps to look after your liver will give it the chance to replace damaged tissue with new cells.

One in three of us is at risk of liver disease. While there are over 100 types of liver disease, with some conditions caused by genetic and autoimmune factors, a staggering 90% of cases are linked to alcohol consumption, excess body weight, diet and viral hepatitis.

Pamela Healy, Chief Executive at the British Liver Trust, said: “Liver disease has been a growing public health concern in the last twenty years during which time deaths have more than doubled with more than 10,000 people dying from the disease every year. Ninety per cent of liver disease is avoidable and sadly, the numbers of people being diagnosed have been increasing at an alarming rate".

The British Liver Trust’s Love Your Liver campaign has three simple but effective steps to improve your liver health:

  • Drink less than 14 units of alcohol and have three consecutive days off alcohol every week.
  • Cut down on sugar, carbohydrates and fat, and take more exercise.
  • Know the risk factors for viral hepatitis and get tested or vaccinated if at risk. There are now highly effective cures for hepatitis.

(Blog supplied by the British Liver Trust)

Become a Trustee at the British Liver Trust
News Type: BASL News

The British Liver Trust is looking for new Trustees to join their Board.

Their Trustees play a pivotal role in providing governance and guidance to ensure they are delivering for people with liver disease and liver cancer. They are involved in setting the strategic direction of the organisation, as well as holding the senior management team to account. The trustees work closely as a team with the senior management team of the charity, playing an active role advising and mentoring as required.

The British Liver Trust is a small charity with big ambitions. They want liver disease to have the same profile and awareness as the other big killer diseases such as heart disease, stroke, and cancer.

They are looking to recruit trustees to help the charity grow and develop to meet this challenge. At this time, they would particularly like:

  • to recruit a clinician with specialist Hepatitis B knowledge, and
  • to broaden the diversity of their Board, particularly ethnic diversity which they recognise as limited currently

The British Liver Trust is committed to improving equality, diversity, and inclusion across the organisation and to building a Board with a variety of backgrounds, skills and views, so that their leadership reflects the population at large and the communities they serve. They also welcome applications from people who have personal experience of liver disease. Please tell us if there may be any barriers to your engagement with us and we will actively work with you to remove these.

They currently have 4 Board meetings a year, usually virtually, Trustees may be asked to sit on a Board sub-committee relevant to their skill set and are invited to get involved in other ways from time to time.

If you have the skills, knowledge and experience required, please ask for a pack from .

If you would like an informal chat with the British Liver Trust Chief Executive, Pamela Healy, please email Helen with your availability so that she can arrange this.

Applications close midnight on 14 February 2024.


2024 Guts UK/Dr Falk Awards
News Type: BASL News

The 2024 Guts UK/Dr Falk Awards are now open to submissions.

These awards recognise the achievements of those who bring new insight to gastroenterology, pancreatology and hepatology, and the collaboration that furthers patient care. They are also an opportunity to achieve national recognition as well as financial support for career progression.

Visit the Guts UK/Dr Falk Awards webpage > here .

There are seven prizes in total available, including a Nurse Recognition Prize.

Deadline - submit your application by Monday 12th February 2024 at 5pm.